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Background: Hepatitis is one of health problems throughout the world. It has numerous consequences on pa-
tients' life. Stigma, depression, social marginalization and ﬁnancial problems are some of the challenges in
these patients.
Aim: The purpose of this qualitative studywas to examine hepatitis-related stigma and discrimination in patients
living with chronic hepatitis in Iranian society.
Methods: This present studywas designed as a qualitativemethod, and this article shows up the results of a qual-
itative research study undertaken with patients living with hepatitis in Iran. The study uses a content analysis
method. A purposive sample of 18 patientswas chosen. Data were collected through a semi-structured interview
and ﬁeld note that the researchers will take during participants' observation. Data analysis process was per-
formed on the texts which were generated from verbatim transcripts of the participants interviews.
Results: Participants were between 18 and 61 years old. The main theme, Stigma, emerged from three themes
during the process data analysis in this study. These themes were including fear to lose of family and social sup-
port, fear to present in public and fear of transmission.
Conclusions: This research indicates that stigma presentsmajor challenges not only for patients livingwith chron-
ic hepatitis but also for nurses, other healthcare practitioners, family and social networks, institutions and society.
The researcher suggests that interventions to reduce or eliminate stigma should require individual, structural,
cultural thought, society and systemic changes.
© 2015 Elsevier Inc. All rights reserved.1. Introduction and background
Hepatitis is a systemic and chronic viral infection which involves
the liver. Hepatitis B is one of the common types of hepatitis and it
is considered as one of the world's health problems (Mohammadi,
HassanpourDehkordi, & NikbakhatNasrabadi, 2013). According to
the published reports, it is estimated that between 350 and 400 million
people suffer from hepatitis B around the world (Alavian, Hajarizadeh,
Ahmadzad-Asl, Kabir, & Bagheri-Lankarani, 2008; Sievert et al., 2011).
The prevalence rate of hepatitis B varies largely in different countries
ranging from 1.2 to 9.7% (Sievert et al., 2011). In Iran, it is estimated
that currently 1.5–2 million Iranians suffer from hepatitis B (Saki et al.,
2013). The incidence rate of hepatitis B is estimated to be 2.14% of
general population. In addition, the incident rate of hepatitis B among
Iranian men and women is reported to be 2.55% and 2.03% respectively
(Saki et al., 2013).cal Sciences, Tehran, I.R. Iran.
(A. HassanpourDehkordi),
akht@tums.ac.irHepatitis C is another type of hepatitis causing chronic disorders in
liver (Khan et al., 2013). It is estimated that about 180 million people
around the world are infected with hepatitis C virus (Mohd Hanaﬁah,
Groeger, Flaxman, & Wiersma, 2013). Like hepatitis B, the prevalence of
this type of hepatitis varies globally ranging from 1% to 5% of the general
population (Sievert et al., 2011). In Iran, the prevalence of hepatitis C is re-
ported less than other eastern mediterranean region countries, and its
prevalence rate is estimated about 1% of general population. Hepatitis C
has high mortality rate among other types of hepatitis and causes at
least 20% of deaths in patients with hepatitis (Alavian et al., 2009).
The chronic nature of hepatitis has many consequences on patients'
life in particular during possible transmission of the disease to vulnerable
people. In the published literature, there are many examples of persons
with hepatitis being evicted from their homes, their jobs, and rejected
by their families, friends and neighbors. Stigma, depression, social mar-
ginalization and ﬁnancial problems are some of the challenges in these
patients which occur due to the complications of the disease and un-
known fear in the patients and their families (Cotler et al., 2012; Kraus,
Sehater, Csef, & Scheurlen, 2005; Mohammadi et al., 2013). Stigma and
discrimination has been reported in association with chronic hepatitis in
the literature (Cotler et al., 2012). However research on hepatitis stigma
and discrimination is limited in the literature (Butt, 2008).
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(Treloar, Rance, & Backmund, 2013). It is an important attribute of the
experience of living with chronic diseases (Bockting, Miner, Swinburne
Romine, Hamilton, & Coleman, 2013), particularly when it is associated
with the possible transmission of the disease to vulnerable people
(Stangl, Lloyd, Brady, Holland, & Baral, 2013). The experience of stigmati-
zation has been identiﬁed by researchers as one of the most signiﬁcant
issues facing people who are hepatitis C positive (Treloar et al., 2013).
Stigmatization of people who suffer from hepatitis C within health care
is a concern not only because of its pervasiveness across all health care
disciplines (Butt, Paterson, & McGuinness, 2008).
There are also widespread reports of discrimination against people
who suffer from hepatitis C in nursing homes, health care settings, hospi-
tals and clinics (Butt et al., 2008). In one research study majority of
respondents with hepatitis C reported that they had been discriminated
by health care workers (Zacks et al., 2006). In another study involving
only injection drug users (IDUs) with hepatitis C, more than 90% of the
respondents indicated they had experienced discrimination enacted by
health care staff (Harris, 2009).
In the last 20 years,most of the research on chronic disease stigma and
discrimination has focused on the attitudes of uninfected persons toward
people living with HIV/AIDS, the role of stigma in HIV/AIDS-related laws,
health care policies, interventions to increase tolerance, and understand-
ing why HIV/AIDS is so highly stigmatized (Greeff et al., 2008).
Little knowledge is available in the literature about hepatitis-related
stigma and discrimination, and there are limited studies using a qualita-
tive method to examine hepatitis-related stigma and discrimination in
patients living with chronic hepatitis particularly in Iran. Therefore, it
needs to conduct more studies to expand the knowledge of hepatitis-
related stigma and discrimination. The purpose of this study was to ex-
plore hepatitis-related stigma and discrimination in patients living with
chronic hepatitis.2. Materials and methods
A descriptive qualitative research method was used to conduct the
present study, and it took place from March 2012 to May 2013.Table 1
Characteristics of the participants.
Participants interviewed (N= 18)
Gender
Male 15 (83%)
Female 3 (17%)
Age (year)
Mean 37 ± 4.25
Education
Did not complete high school 11 (61%)
High school diploma 6 (33%)
Postsecondary 1 (6%)
Source of infection
Needle-stick or work exposure 1 (6%)
Illicit drug use 10 (55/5%)
Blood transfusion 2 (11/11%)
Unknown 5 (27/4%)
Economic status
Week (less than $200 per month) 10 (55%)
Moderate (between $200 to $500 per month) 6 (33/8%)
Good (more than $500 per month) 2 (11/2%)2.1. Participants and recruitment
Selection criteria of participantswere aged between18 to 61 year-old,
living with chronic hepatitis B or C for at least 6 months, able to partici-
pate in the face-to-face interview; and consent to participate in the
study. Participants recruited through a purposeful sampling method
from counseling ofﬁce in the health care centers. Participants were re-
cruited through different recruitment strategies including poster and
ﬂyer distribution, key people and direct contact in the health centers.
Posters andﬂyerswere distributed at counseling ofﬁces in the health cen-
ters, local hepatitis service organizations and medical clinics. Information
on the posters and ﬂyers brieﬂy stated the nature and purpose of the
study and encouraged interested participants to contact the researcher.
The ﬁrst contact with the study participants wasmade by the princi-
ple researcher. The researcher explained the level of involvement of
participants and answered to any potential questions of the partici-
pants. The researchers also explain the need for audio-taped interview
in order to have an exact recording of their experience thatwould assist
the researchers in analysis of data. Also the risks and beneﬁts of the
study, measures taken to ensure conﬁdentiality, the voluntary nature
of participation, ability to withdraw from the study without penalty
and research data protection procedures were discussed during the in-
formed consent process.
Participants were 18 people (83% male and 17% female) with chronic
hepatitis, aged between 18 and 61 year-old (37± 4.25). Table 1 presents
more demographic characteristics detail of participants.2.2. Data collection process
In this study, data were collected through a semi-structured, in-depth
interview and ﬁeld note that the researcher's took during participants'
observation. The location for the interviews was in a quiet room in the
counseling ofﬁce in health centers or local hepatitis service organizations.
The participants informed that they could have a close family member or
friend during the interview, if they preferred. In addition, participant
completed the consent form prior to the audio-taped interviews. The
researchers began the interview with an informal talk. The purpose of
this informal talk was to establish relationship with the participants in
order to build trust. There is no formal protocol to follow with speciﬁc
questions asked.
Following questions were used as guiding questions during inter-
views. “What does hepatitis mean to you?”; “Did you face difﬁculty in
relation to your illness?” What should the attitude towards hepatitis
management be”? “How has hepatitis affected your life”? And how is
your social life affected by your disease. Towards the end of every inter-
view, the researchers afforded each participant the opportunity to add
anything to the discussion by asking the following question: “Is there
anything else that you feel is relevant and you would you like to add?”
The interview sessions ranged from 40 to 65 minutes. Each interview
transcribes verbatim into a word processor as soon as possible. Following
verbatim transcription, the researchers read the transcriptswhile listening
to the tapes to check accuracy of texts prior to analysis. Then the re-
searchers commenced thedata analysis process on thewritten transcripts.
2.3. Data analysis
Data analysis was done through a constant-comparative thematic
analysis. The ﬁrst stage of the analytic process was preparation of an in-
terview guide including broad and open-ended questionswhich enabled
the participants to express their viewpoint comprehensively. In the sec-
ond stage, all the transcripts were read several times, and all transcripts
were examined line by line to identify the participants' descriptions of
thought patterns, feelings, and actions related to the themes mentioned
in the interviews. Then the text about the participants' experiences of
having hepatitis was extracted and brought together into one text,
which constituted the unit of analysis. The textwas divided intomeaning
units that were condensed. The condensedmeaning units were abstract-
ed and labeledwith a code. The codes derivedwere formulated inwords
used by the participant; thiswas an attempt tomaintain the semantics of
the data. The codes were sorted into categories and sub-categories,
which constitute the manifest content. The tentative categories were
discussed by researchers and revised. What differed between the
researchers was their judgment about what comprised familiar and un-
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sulted in agreement about how to sort the codes. Finally, the underlying
meaning, that is, the latent content, of the categories, was formulated
into a theme.
2.4. Study rigor
Researchers utilized the assessment criteria of Guba and Lincoln. For
this purpose, numerous methods were used to examine the credibility
of data such as check member, peer debrieﬁng, searching for
disconﬁrming evidence and prolonged engagement with data. Transfer-
ability was considered by having a team. The ﬁnal categories were deter-
mined by the entire study team. The research methods were employed
and carefully elaborated that readers could follow the research process.
Finally conformity was assessed by researcher attempts to mention all
steps of the research, to enable reader to pursue data.
2.5. Ethical approval
The study had been approved by the Ethical Committee of Tehran
University of Medical Sciences. Participants ensured about keeping per-
sonally identiﬁable information conﬁdential and to keep the transcrip-
tions anonymous and the audiotapes secured. Participants also ﬁlled
out a written agreement for participation to the study and recording
the interviews. All the participants signed a written consent form at the
beginning of the interview.
3. Results
In the process of data analysis, stigma was the main theme that
emerged from the participants' interviews. Stigma emerged from three
sub-themes including fear to lose of family and social support, fear to
present in public and fear of transmission.
3.1. Fear to lose family and social support
Fear to lose family and social supportwas one of the consequences of
stigma in the participants. Participants believed that theywould lose the
support of family and friends if their family knew that they have hepa-
titis. Therefore they were always feeling that they would be humiliated
by familymembers and friends if they know the participants' illness. For
example, one of the participants told me:
When I found out that I had hepatitis, I wasworried….I cried frequently
and didn’t knowhow to informmyhusband aboutmy status. I waswor-
ried about what he would think, that maybe I had contacts with other
men. I was thinking that it could be shame to have hepatitis from my
family perspectives.
Participants' fear had diverse meaning and perception of lost family
and social support. For some of the participants, lost family and social
support was changing the way their family members and friends be-
haved with them. As a participant said, “My wife didn't communicate
with me. Didn't have meal with me, avoided me and was severely fright-
ened…”. However, it was a threat for some other participants that they
would be divorced. The following manuscript has been taken from
one of the participants. He pointed out that "She divorced me when she
knew I have hepatitis. …..I thought hepatitis is like ﬂu, I did not assume
that people like my wife recognize hepatitis as a embarrassing illness!!!”.
Fear to lose social support was expressed as fear of the misbehavior
and misconduct of healthcare professionals. Participants explained that
they were feeling that health professionals do not like to look after pa-
tients with hepatitis. Therefore they would neglect them if they know
they have hepatitis. The following text from one of the participants pro-
vides a typical example.As soon as my surgeon found out that I have hepatitis, he got reluctant
to do surgery. At that time, I thought how bad is my illness that my sur-
geon does not like to do surgery any more!
Other participants added that
When I had fracture in my leg, I was admitted to the hospital. After ad-
mission, I said to the doctor that I have hepatitis. He did discharge me
from hospital right away and asked me to go to governmental hospital.
I was feeling bad after discharging from hospital. I went to another hos-
pital and did not tell the health professional about my illness.
Participants will easily solve their problems when they are support-
ed by others. Additionally, husbands and family are important sources
of encouragement, also health professionals, including nurses, are sig-
niﬁcant roles in the acceptance and support.
3.2. Fear to present in public
Majority of participants believed that publics had a negative attitude
towards hepatitis. Therefore they were unwilling to go to public and be
socialized. For example, the following statements were taken from one
of the participant's interview.
People think that hepatitis is look like a dragon! Because of such nega-
tive perception among people, I prefer to stay home and not going out.
I always get uncomfortable when I see people stare me. That is why I
keep my illness as a secret.
"Because people think hepatitis means stigma, I always send my
mother, instead of running the errand myself to the Health centers
to fetch my drugs.
Some of participants pointed out that hepatitis has destroyed their so-
cial life and they insisted that public avoid to interact with people who
suffer from hepatitis. This quotation is taken from one of the participants.
“People think hepatitis is something worse than drug addiction and
vampire.…..People cannot stand a patient with hepatitis.”
Negative feelings and moral judgments of those with hepatitis by
healthcare providers, family, friendship networks and society serve as
socially surrounded controls that set the person separately from society
and hide his or her disease.
3.3. Fear of transmission
Stigma was a consequence of fear of transmission. Participants be-
lieved that fear of transmission among family members, relative and
friends originated from lack of knowledge about the transmission of
routes of hepatitis.
I always was going out with my friends for coffee and dinner. ….since I
told them that I suffer from hepatitis, everybody refuse to go out with
me. They also avoid shaking hands with me. Even if I see them in coffee
bar or restaurant, they suddenly leave there. They don’t know shaking
hands is not the way to transmit hepatitis. ….you know it’s not just my
friends, I know even my brothers are unwilling to shake hands with me.
One of the participants added that his wife gets very upset when he
held or kissed their baby. He also explained that she avoids children to
eat meal when I am eating. The following excerpts are an example
which was declared by one of the participants."When my wife found
that I have hepatitis, she try to keep a distant with me. She ask me to use
disposable cutlery and dishes. She discards them after I used."
Participants were always concerned if their family members, relatives
and friends were infected with hepatitis; they would be embarrassed. "I
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about virus transmission. I explained her that the virus doesn’t transmit if I
use condom.”
4. Discussion
In this study, one of the themeswas fear to lose family and social sup-
port that contributed to stigma for chronic hepatitis patients. Participants'
statements about access to care and support resources were insufﬁcient
(Maria et al., 2010). The family is an important source of care and support
for patients with hepatitis (Maman et al., 2009a). The results of the cur-
rent study were similar with other studies (Greeff et al., 2008; Holzemer
et al., 2007). Also Fife andWright reported thatwomenwithHIV/AIDS are
hesitant to access health care for fear of discovery. They are unwilling to
take medications and nursing service that identify them as being ill and
require explanations. They feel obliged to tell the health care professional
but worry that their conﬁdentiality will be breached or the provider will
reject and mock them (Fife & Wright, 2000).
The participants in this study were hesitant to inform others about
their illness because they fear rejection by family members, relatives
and friends. This was not limited to family members and friends but
also included health care providers and employers. This hesitancy
presented a barrier to their seeking health care and both formal and
informal support. Taking medications and maintaining employment
while not disclosing their hepatitis status required that they make
choices regarding medication (Cotler et al., 2012). Therefore, these
challenges had the potential to limit their access to health care, social
support, medications and employment. Previous studies have described
how poor access to health-related resources is associated with stigma
and is a powerful expression of stigma in settings where communities
feel overwhelmed in caring for people with HIV (Maman et al., 2009b).
The nurseswho provide counseling or therapy to chronic hepatitis people
can help them make informed decisions about the risks and beneﬁts of
status concealment. Chronic hepatitis people who feel seriously stigma-
tized and use more hiding strategies will likely experience increased
stress and risk closing off access to the social support needed to facilitate
adaptation to the illness.
Fear to present in public was another sub-theme to lead hepatitis-
related stigma. The result showed that stigma management was highly
dependent on social context. In this study, most of the participants
remarked that the stigma has devastated their life, making them frustrat-
ed, depressed and isolated. They insisted that theywere hiding their own
disease. The results of the study are consistent with previous research
showing that hepatitis patients seek to ﬁnd hiding strategies to protect
themselves from stigma (Bockting et al., 2013; Treloar et al., 2013).
Fear of transmission was the most common report cited the with-
drawal of care, support, or services by health care practitioners. It involves
refusing to care for the person with chronic hepatitis by health profes-
sionals. For example, some participants indicated that nurses and doctors
were reluctant and took a step back when they found out that they suffer
from hepatitis. Findings in other research indicated that the majority of
patients are not given dental services. Other studies, also, suggest that
the health professionals who deal with hepatitis or HIV patients are dis-
criminatory and unwilling to provide health service to patients with hep-
atitis. In relation todifﬁculties in patients' access to health services, studies
found out that health professionals behave differently with patients who
have hepatitis (Stangl et al., 2013; Treloar et al., 2013).
Nurses and health team have important role to help these group of
patients to adapt with their own illness. Patients with chronic hepatitis
need counseling for a range of issues including being labeled, inadequate
knowledge, hopelessness, physical, economic and psychological difﬁcul-
ties. However hepatitis-related stigma hides them to seek for health
care support and counseling. Other studies also revealed that people
who experience stigma, need health professional support (Bockting
et al., 2013; Maman et al., 2009a). In addition, it has been revealed in
many studies that lack of knowledge, frustration, physical, economicaland psychological challenges can intensify the effect of stigma on patients
(Butt et al., 2008; Mohamadpour, 2010).
5. Conclusion
Stigma is a complex social construct that is inﬂuenced by bio-
pyschosocial, cultural and economic factors. Chronic hepatitis-related
stigma is an emerging conceptwith relevance to the stigmaof other infec-
tious diseases. However, the central and distinctive features of chronic
hepatitis-related stigma in Iran are lack of health care and support system
special in patients living with chronic hepatitis, inadequate or loss of
knowledge, and negative attitude. Chronic hepatitis-related stigma indi-
cates that stigmapresentsmajor challenges not only for thosewith chron-
ic hepatitis, but also for health professionals, family and social networks,
institutions and community. The researcher suggests that interventions
to reduce or eliminate stigma will require individual, structural, cultural
thought, society and systemic changes. Health care system team should
develop interventions in order to eliminate the chronic hepatitis-related
stigma and reduce fear of hepatitis among people in the community
through public education.
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